Low prevalence of mupirocin resistance among hospital-acquired methicillin- resistant Staphylococcus aureus isolates in a neonatal intensive care unit with an active surveillance cultures and decolonization program

Infection Control and Hospital Epidemiology

Volumn 36, Issue 2, 2015, Pages 232-234

  Suwantarat, Nuntra ^a   Carroll, Karen C ^a,b   Tekle, Tsigereda ^b   Ross, Tracy ^b   Popoola, Victor O ^a   Milstone, Aaron M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE GLUCONATE; PSEUDOMONIC ACID; ANTIINFECTIVE AGENT;

ABDOMINAL INJURY; ANTIBIOTIC RESISTANCE; ARTICLE; EPSILOMETER TEST; HOSPITAL MANAGEMENT; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; OUTCOME ASSESSMENT; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; RNA GENE; CROSS INFECTION; DRUG EFFECTS; HEALTH SURVEY; HETEROZYGOTE; INFECTION CONTROL; INTRANASAL DRUG ADMINISTRATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; NEWBORN INTENSIVE CARE; STAPHYLOCOCCAL INFECTIONS;

ADMINISTRATION, INTRANASAL; ANTI-BACTERIAL AGENTS; CARRIER STATE; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INFANT, NEWBORN; INFECTION CONTROL; INTENSIVE CARE UNITS, NEONATAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MUPIROCIN; POPULATION SURVEILLANCE; STAPHYLOCOCCAL INFECTIONS;

EID: 84922709505     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1017/ice.2014.17     Document Type: Article

References (10)

1. Patel JB, Gorwitz RJ, Jernigan JA. Mupirocin resistance. Clin Infect Dis 2009;49:935-941.
2. McDanel JS, Murphy CR, Diekema DJ, et al. Chlorhexidine and mupirocin susceptibilities of methicillin-resistant Staphylococcus aureus from colonized nursing home residents. Antimicrob Agents Chemother 2013;57:552-558.
3. Fritz SA, Hogan PG, Camins BC, et al. Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. Antimicrob Agents Chemother 2013;57:559-568.
4. Popoola VO, Budd A, Wittig SM, et al. Methicillin-resistant Staphylococcus aureus transmission and infections in a neonatal intensive care unit despite active surveillance cultures and decolonization: challenges for infection prevention. Infect Control Hosp Epidemiol 2014;35:412-418.
5. Huang YC, Chou YH, Su LH, et al. Methicillin-resistant Staphy- lococcus aureus colonization and its association with infection among infants hospitalized in neonatal intensive care units. Pediatrics 2006;118:469-474.
6. Popoola VO, Carroll KC, Ross T, Reich NG, Perl TM, Milstone AM. Impact of colonization pressure and strain type on methicillin-resistant Staphylococcus aureus transmission in children. Clin Infect Dis 2013;57:1458-1460.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 24th informational supplement CLSI M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA. 2014.
8. Delaney HM, Wang E, Melish M. Comprehensive strategy including prophylactic mupirocin to reduce Staphylococcus aureus colonization and infection in high-risk neonates. J Perinatol 2013;33:313-318.
9. Hitomi S, Kubota M, Mori N, et al. Control of a methicillinresistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment. J Hosp Infect 2000;46:123-129.
10. Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996;17:811-813.